Ménière's disease review 2005

Journal of the American Academy of Audiology

Volumn 17, Issue 1, 2006, Pages 16-26

  Gates, George A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Hydrops; M ni re's disease; Otoacoustic emissions; Therapy; Treatment; Vertigo; Vestibular

Indexed keywords

ACETAZOLAMIDE; ANESTHETIC AGENT; BETAHISTINE; CORTICOSTEROID; DIURETIC AGENT; GENTAMICIN; HISTAMINE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; PLACEBO;

CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; DECOMPRESSION SURGERY; DISEASE ASSOCIATION; HEARING LOSS; HUMAN; INNER EAR DISEASE; LABYRINTHECTOMY; MENIERE DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; SODIUM RESTRICTION; SURGICAL DRAINAGE; TREATMENT PLANNING; TYMPANOSTOMY TUBE; VERTIGO; EVOKED BRAIN STEM AUDITORY RESPONSE; EVOKED RESPONSE AUDIOMETRY; INNER EAR; METABOLISM; PATHOLOGY; TINNITUS;

AUDIOMETRY, EVOKED RESPONSE; EAR, INNER; ENDOLYMPHATIC HYDROPS; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; HEARING LOSS; HUMANS; MENIERE'S DISEASE; TINNITUS; VERTIGO;

EID: 33747358674     PISSN: 10500545     EISSN: None     Source Type: Journal    
DOI: 10.3766/jaaa.17.1.3     Document Type: Review

References (70)

1. Arriaga M, Goldman S. (1998) Hearing results of intratympanic steroid treatment of endolymphatic hydrops. Laryngoscope 108:1682-1685.
2. Baloh R. (1997) Neurotology of migraine. Headache 37:615-621.
3. Blakley B. (2000) Update on intratympanic gentamicin for Meniere's disease. Laryngoscope 110:236-240.
4. Boedts D, Vandenhove P. (1969) Droperidol-fentanyl citrate in equilibratory disturbances. Arch Otolaryngol 89:715-719.
5. Brookes G, Booth J. (1984) Oral acetazolamide in Meniere's disease. J Laryngol Otol 98:1087-1095.
6. Brookes G, Morrison A, Booth J. (1982) Acetazolamide in Meniere's disease: evaluation of a new diagnostic test for reversible endolymphatic hydrops. Otolaryngol Head Neck Surg 90:358-366.
7. Campbell K, Harker L, Abbas P. (1992) Interpretation of electrocochleography in Menière's disease and normal subjects. Ann Otol Rhinol Laryngol 101:496-500.
8. Conlon B, Gibson W. (2000) Electrocochleography in the diagnosis of Meniere's disease. Acta Otolaryngol 120:480-483.
9. Couloigner V, Berrebi D, Teixeira M, Paris R, Florentin A, Bozorg G, Cluzeaud F, Sterkers O, Peuchmaur M, Ferrary E. (2004) Aquaporin-2 in the human endolymphatic sac. Acta Otolaryngol 124:449-453.
10. Dederding D. (1929) Clinical and experimental examinations in patients suffering from M. Meniere: including a study of the problem of bone conduction. Acta Otolarynogol Suppl (Stockh) 10:1-156.
11. Densert O, Carlborg B, Stagg J. (1979) Pressure-regulating mechanisms in the inner ear. ORL J Otorhinolaryngol Relat Spec 40:319-324.
12. Densert B, Densert O. (1982) Overpressure in treatment of Meniere's disease. Laryngoscope 92:1285-1292.
13. Densert B, Densert O, Erlandsson B, Sheppard H. (1986) Transmission of complex pressure waves through the perilymphatic fluid in cats. Acta Otolaryngol 102:403-409.
14. Densert B, Sass K. (2001) Control of symptoms in patients with Meniere's disease using middle ear pressure applications: two years follow-up. Acta Otolaryngol 121:616-621.
15. Don M, Kwong B, Tanaka C. (2005) A diagnostic test for Meniere's disease and cochlear hydrops: impaired high-pass noise masking of auditory brainstem responses. Otol Neurotol 26(4):711-712.
16. Furstenberg AC, Lashmet FH, Lathrop FD. (1934) Meniere's symptom complex: medical treatment. Ann Otol Rhinol Laryngol 43:1035-1047.
17. Gates G, Green J, Tucci, Telian S. (2004) The effect of transtympanic micropressure treatment in people with unilateral Meniere's disease. Arch Otolaryngol Head Neck Surg 130:718-725.
18. Gianoli G, LaRouere M, Kartush J, Wayman J. (1998) Sac-vein decompression for intractable Meniere's disease: two-year treatment results. Otolaryngol Head Neck Surg 118:22-29.
19. Gibson W. (1996) The effect of surgical removal of the extraosseous portion of the endolymphatic sac in patients suffering from Meniere's disease. J Laryngol Otol 110:1008-1011.
20. Gibson W, Arenberg I. (1997) Pathophysiologic theories in the etiology of Meniere's disease. Otolaryngol Clin North Am 30:961-967.
21. Gibson W, Prasher D. (1983) Electrocochleography and its role in the diagnosis and understanding of Meniere's disease. Otolaryngol Clin North Am 16:59-68.
22. Goldenberg R, Justus M. (1983) Endolymphatic mastoid shunt for treatment of Meniere's disease: a five year study. Laryngoscope 93:1425-1429.
23. Gulya A, Schuknecht H. (1982) Classification of endolymphatic hydrops. Am J Otolaryngol 3:319-322.
24. Hallpike C, Cairns H. (1938) Observations on the pathology of Meniere's syndrome. J Laryngol Otol 53:625-655.
25. House W. (1965) Symposium: management of Meniere's disease. VII. Subarachnoid shunt for drainage of hydrops. A report of 146 cases. Laryngoscope 75:1547-1551.
26. Hrobjartsson A, Gotzsche P. (2001) Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 344:1594-1602.
27. Huang T, Lin C, Chang Y. (1991) Endolymphatic sac surverv for Menière's disease. A cumulative study of twelve years' experience. Acta Otolaryngol Suppl (Stockh) 485:145-154.
28. Hughes G, Kinney S, Barna B, Calabrese L. (1983) Autoimmune reactivity in Meniere's disease: a preliminary report. Laryngoscope 93:410-417.
29. Johnson J, Wal C, Barney S, Thearle P. (1985) Postoperative vestibular dysfunction following head and neck surgery. Acta Otolaryngol 100:316-320.
30. Kimura R. (1976) Experimental pathogenesis of hydrops. Arch Otorhinolaryngol 212:263-275.
31. Klockhoff I, Lindblom U, Stable J. (1974) Diuretic treatment of Meniere disease. Long-term results with chlorthalidone. Arch Otolaryngol 100:262-265.
32. Magliulo G, Cianfrone G, Triches L, Altissimi G, D'Amico R. (2001) Distortion-product otoacoustic emissions and glycerol testing in endolymphatic hydrops. Laryngoscope 111:102-109.
33. Margolis R, Rieks D, Fournier E, Levine S. (1995) Tympanic electrocochleography for diagnosis of Meniere's disease. AMA Arch Otolaryngol Head Neck Surg 121:44-55.
34. McCabe B, Harker L. (1983) Vascular loop as a cause of vertigo. Ann Otol Rhinol Laryngol 92:542-543.
35. Morrison A, Moffat D, O'Connor A. (1980) Clinical usefulness of electrocochleography in Meniere's disease: an analysis of dehydrating agents. Otolaryngol Clin North Am 13:703-721.
36. Morrison A, Mowbray J, Williamson R, Sheeka S, Sodha N, Koskinen N. (1994) On genetic and environmental factors in Meniere's disease. Am J Otol 15:35-39.
37. Naftalin L. (2001) Endolymphatic hydrops induced by chronic administration of vasopressin. Hear Res 155:181-182.
38. Nedzelski J, Schessel D, Bryce G, Pfleiderer A. (1992) Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Menière's disease. Am J Otol 13:18-22.
39. Odkvist L, Arlinger S, Billermark E, Densert B, Lindholm S, Wallqvist J. (2000) Effects of middle ear pressure changes on clinical symptoms in patients with Meniere's disease - a clinical multicentre placebo-controlled study. Acta Otolaryngol Suppl 543:99-101.
40. Odkvist L, Bergenius J, Moller C. (1997) When and how to use gentamicin in the treatment of Meniere's disease. Acta Otolaryngol Suppl 526:54-57.
41. Paparella M. (1985) The cause (multifactorial inheritance) and pathogenesis (endolymphatic malabsorption) of Meniere's disease and its symptoms (mechanical and chemical). Acta Otolaryngol 99:445-451.
42. Paparella M, Sajjadi H. (1994) Endolymphatic sac enhancement. Otolaryngol Clin North Am 27:381-402.
43. Pender D. (1985) Gentamicin tympanoclysis: effects on the vestibular secretory cells. Am J Otolaryngol 6:358-367.
44. Portmann G. (1926) Vertigo surgical treatment by the opening of saccus endolymphaticus. Arch Otolaryngol 6:309.
45. Proctor B, Proctor C. (1981) Metabolic management in Meniere's disease. Ann Otol Rhinol Laryngol 90:615-618.
46. Proctor C, Proctor T, Proctor B. (1992) Etiology and treatment of fluid retention (hydrops) in Ménière's syndrome. Ear Nose Throat J 71:631-635.
47. Qvortrup K, Rostgaard J, Holstein-Rathlou N. (1996) The inner ear produces a natriuretic hormone. Am Physiol Soc 270:F1073-F1077.
48. Qvortrup K, Rostgaard J, Holstein-Rathlou N, Bretlau P. (1999) The endolymphatic sac, a potential endocrine gland? Acta Otolaryngol 119:194-199.
49. Rauch S, Zurakowski D, Bloch D, Bloch K. (2000) Anti-heat shock protein 70 antibodies in Meniere's disease. Laryngoscope 110:1516-1521.
50. Ruckenstein MJ, Rutka JA, Hawke M. (1991) The treatment of Meniere's disease: Torok revisited. Laryngoscope 101(2):211-218.
51. Sakikawa Y, Kimura R. (1997) Middle ear overpressure treatment of endolymphatic hydrops in guinea pigs. ORL J Otorhinolaryngol Relat Spec 59:84-90.
52. Salt A, DeMott J. (1994) Time course of endolymph volume increase in experimental hydrops measured in vivo with an ionic volume marker. Hear Res 74:165-172.
53. Salt A, Rask-Andersen. (2004) Responses of the endolymphatic sac to perilymphatic injections and withdrawals: evidence for the presence of a one-way valve. Hear Res 191:90-100.
54. Schuknecht H. (1975) Pathophysiology of Meniere's disease. Otolaryngol Clin North Am 8:507-514.
55. Smith W, Pillsbury H. (1988) Surgical treatment of Meniere's disease since Thomsen. Am J Otol 9:39-43.
56. Stable J, Stable C, Arenberg. (1978) Incidence of Meniere's disease. Arch Otolaryngol 104:99-102.
57. Stankovic K, Adams J, Brown D. (1995) Immunolocalization of aquaporin CHIP in the guinea pig inner ear. Am J Physiol 269:C1450-C1456.
58. Telischi F, Luxford W. (1993) Long-term efficacy of endolymphatic sac surgery for vertigo in Menière's disease. Otolaryngol Head Neck Surg 109:83-87.
59. Thomsen J, Bretlau P, Tos M, Johnsen N. (1981) Placebo effect in surgery for Meniere's disease. A double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol 107:271-277.
60. Thomsen J, Bretlau P, Tos M, Johnsen N. (1986) Endolymphatic sac-mastoid shunt surgery. A non-specific treatment modality?Ann Otol Rhinol Laryngol 95:32-35.
61. Thomsen J, Sass K, Odkvist L, Arlinger S. (2005) Local overpressure treatment reduces vestibular symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study. Otol Neurotol 26:68-73.
62. Torok N. (1977) Old and new in Meniere disease. Laryngoscope 87:1870-1877.
63. van Deelen GW, Huizing EH. (1986) Use of a diuretic (Dyazide) in the treatment of Meniere's disease: double-blind cross-over placebo-controlled study. ORL J Otorhinolaryngol Relat Spec 48(5):287-292.
64. van Huffelen W, Mateijsen N, Wit H. (1998) Classification of patients with Meniere's disease using otoacoustic emissions. Audiol Neurootol 3:419-430.
65. Varga G, Miriszlai E, Szab'o L. (1966) Experiences with acetazolamid therapy applied in our clinic to patients suffering from Meniere's disease for more than 8 years. J Laryngol Otol 80:250-269.
66. Watanabe Y, Mizukoshi K, Shojaku H, Watanabe I, Hinoki M, Kitahara M. (1995) Epidemiological and clinical characteristics of Meniere's disease in Japan. Acta Otolaryngol Suppl 519:206-210.
67. Wilmot T. (1972) The effect of betahistine hydrochloride in Ménière's disease. Acta Otolaryngol (Stockh) 305:18-21.
68. Wladislavosky W, Facer G, Mokri B, Kurland L. (1984) Meniere's disease: a 30-year epidemiologic and clinical study in Rochester, Mn, 1951-1980. Laryngoscope 94:1098-1102.
69. Yamakawa K. (1938) Uber die pathologische Veranderung bei einem Meniere-Kranken. J Otorhinolaryngol Soc Jpn 4:2310-2312.
70. Yazawa Y, Kitahara M. (1994) Computerized tomographic findings in endolymphatic sac surgery in Meniere's disease. Acta Otolaryngol Suppl (Stockh) 510:73-76.